3 terminated. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 3 |
| Phase 1 | 1 | Terminated 1 |
Follow Systemic Scleroderma: new trials by email Literature Review of Systemic Scleroderma trials Research Report on Systemic Scleroderma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Patients With Systemic Sclerosis With Interstitial Lung Disease Pomalidomide (CC-4047), Placebo - Scleroderma, Systemic, Sclerosis, Systemic | Phase 2 | Terminated | Celgene | 23 | 2012-08-09 | 2023-12-01 |
| Effectiveness of UVA1-irradiation in the Treatment of Early Skin Fibrosis in Patients Suffering From Systemic Sclerosis UVA1 - Systemic Scleroderma, Systemic Sclerosis | Phase 1 / Phase 2 | Terminated | Nicolas Hunzelmann | 9 | 2008-02-01 | 2017-05-31 |
| Placebo Controlled Trial of Bosentan in Scleroderma Patients Bosentan, Placebo - Systemic Scleroderma, Pulmonary Hypertension | Phase 2 | Terminated | Georgetown University | 5 | 2006-09-01 | 2018-05-24 |
Scleroderma, Systemic (3) · Hypertension, Pulmonary (1) · Lung Diseases, Interstitial (1) · Scleroderma, Diffuse (1)
Connective Tissue Diseases (3) · Skin Diseases (3) · Skin and Connective Tissue Diseases (3) · Lung Diseases (2) · Respiratory Tract Diseases (2) · Cardiovascular Diseases (1) · Hypertension (1) · Vascular Diseases (1)
Bosentan (1) · Ultraviolet Rays (1) · pomalidomide (1)
Celgene (1) · Georgetown University (1) · Nicolas Hunzelmann (1)
Germany (2) · United States (2) · Australia (1) · France (1) · Italy (1) · Poland (1) · Russia (1) · Spain (1) · Switzerland (1) · United Kingdom (1)
Nicolas Hunzelmann (1) · Shimon Korish, MD (1) · Virginia D Steen, MD (1)